CKS1B and plasma cell myeloma: Since the STAT3 and MEK/ERK signaling pathways were both involved in CKS1B-induced myeloma cell growth and survival, a combined targeting of these signaling pathways might induce synergistic cytotoxicity in myeloma cells.